Risk of parathyroid adenomas in patients with thyrotoxicosis exposed to radioactive iodine.
External ionizing radiation is a risk factor for primary hyperparathyroidism. Whether exposure to radioactive iodine contributes to the risk of primary hyperparathyroidism is unknown. Patients with thyrotoxicosis are often treated with radioactive iodine and its accumulation in the thyroid gland exposes the adjacent parathyroid glands to radioactivity. Six thousand and eighty two patients with thyrotoxicosis (ICD-9 = 242) were identified from medical records. In a randomly selected subcohort we assessed the frequency of treatment with radioactive iodine to be 86%. The number of patient-years at risk was 77,118. Patients with parathyroid adenomas (ICD-9 = 195.1) were recruited from the Swedish Cancer Registry. Eleven patients with parathyroid adenomas following the diagnosis of thyrotoxicosis were identified. The standard incidence ratio (SIR) compared to the reference population of approximately 900,000 was 1.14 (95% CI 0.57-2.03). The median age at exposure was 59 years and the latency period between diagnosis of thyrotoxicosis and parathyroid adenoma was 7.4 years (range <1-19 years). This study does not indicate that patients with thyrotoxicosis treated with radioactive iodine in adult age have increased risk of developing parathyroid adenoma.
Rasmuson
Torgny
T
Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden. torgny.rasmuson@onkologi.umu.se
Tavelin
Björn
B
D000236:Adenoma / Q000453:epidemiology / Q000209:etiology*; D000328:Adult; D000368:Aged; D000818:Animals; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010282:Parathyroid Neoplasms / Q000453:epidemiology / Q000209:etiology*; D051381:Rats; D012306:Risk; D013971:Thyrotoxicosis / Q000532:radiotherapy*
D007457:Iodine Radioisotopes